HCV genotype 1a and 1b: Similarities and differences in clinical features, therapeutic outcome and predictors of response
โ Scribed by Morisco, F.; Di Marco, V.; Caporaso, N.; Granata, R.; Camera, S.; Ippolito, A.; Margaglione, M.; Fattovich, G.; Smedile, A.; Clery, E.; Ferraiuoli, C.; Guarino, M.; Donnarumma, L.; Valvano, M.R.; Milella, M.; Felder, M.; Gaeta, G.B.; Gatti, P.; Tundo, P.; Barone, M.; Cozzolongo, R.; Angelico, M.; Mazzella, G.; Santantonio, T.; Andriulli, A.
- Book ID
- 122246459
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 55 KB
- Volume
- 46
- Category
- Article
- ISSN
- 1590-8658
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Plasma from 173 patients with HCV genotype 1 infection was analyzed for IP-10 levels prior to treatment with pegylated interferon-โฃ-2a and ribavirin. Significantly lower IP-10 levels were observed in patients achieving a rapid viral response (RVR) (P < .0001), even in those with body mass index (BMI